{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:15:43Z","timestamp":1791249343927,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.psyneuen.2025.107477","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:46:06Z","timestamp":1746056766000},"page":"107477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Salivary cortisol trajectories among inpatients undergoing substance use disorder treatment: A prospective repeated-measures study"],"prefix":"10.1016","volume":"178","author":[{"given":"Eli","family":"Otterholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Laake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e5l","family":"Bj\u00f8rkly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Wessel","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.psyneuen.2025.107477_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.psyneuen.2009.06.011","article-title":"Assessing salivary cortisol in large-scale, epidemiological research","volume":"34","author":"Adam","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib2","article-title":"Factors associated with quality of life trajectories among inpatients treated for alcohol use disorders: A prospective cohort study","volume":"12","author":"Andersson","year":"2020","journal-title":"Addict. Behav. Rep."},{"key":"10.1016\/j.psyneuen.2025.107477_bib3","first-page":"1","article-title":"Predictors of dropout from inpatient substance use treatment: A prospective cohort study","volume":"12","author":"Andersson","year":"2018","journal-title":"Subst Abuse Res Treat."},{"key":"10.1016\/j.psyneuen.2025.107477_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addbeh.2018.11.008","article-title":"Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances","volume":"90","author":"Andersson","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.psyneuen.2025.107477_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tips.2010.04.005","article-title":"Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome","volume":"31","author":"Armario","year":"2010","journal-title":"Trends Pharmacol Sci."},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107477_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0893-133X(01)00308-6","article-title":"Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor","volume":"26","author":"Barr","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107477_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13556210020040235","article-title":"Checkley S. Salivary cortisol during opiate dependence and withdrawal","volume":"6","author":"Bearn","year":"2001","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib8","article-title":"Is there an association between salivary cortisol and dropping out of inpatient substance addiction treatments? A prospective repeated measures study","volume":"16","author":"B\u00f8hle","year":"2022","journal-title":"Subst. Use"},{"issue":"8","key":"10.1016\/j.psyneuen.2025.107477_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","article-title":"Drop-out from addiction treatment: A systematic review of risk factors","volume":"33","author":"Brorson","year":"2013","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psyneuen.2025.107477_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.psyneuen.2011.12.010","article-title":"Acute psychosocial stress: does the emotional stress response correspond with psychological responses","volume":"37","author":"Campbell","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.psyneuen.2025.107477_bib11","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.3390\/ijms24054575","article-title":"A closer look at opioid-induced adrenal insufficiency: a narrative review","volume":"24","author":"Coluzzi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2025.107477_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fpsyt.2018.00472","article-title":"Marijuana use and hypothalamic-pituitary-adrenal axis functioning in humans","volume":"9","author":"Cservenka","year":"2018","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107477_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2009.06.026","article-title":"HPA axis response to psychological stress and treatment retention in residential substance abuse treatment: a prospective study","volume":"105","author":"Daughters","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107477_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bs.3830190102","article-title":"The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory","volume":"19","author":"Derogatis","year":"1974","journal-title":"Syst. Res Behav. Sci."},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107477_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1037\/0033-2909.130.3.355","article-title":"Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research","volume":"130","author":"Dickerson","year":"2004","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.psyneuen.2025.107477_bib16","first-page":"1","article-title":"Trajectories of psychological distress during recovery from polysubstance use disorder","author":"Erga","year":"2020","journal-title":"Addict. Res Theory"},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107477_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hup.2280","article-title":"Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine","volume":"28","author":"Fox","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107477_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpsycho.2008.03.014","article-title":"The cortisol awakening response (CAR): facts and future directions","volume":"72","author":"Fries","year":"2009","journal-title":"Int J. Psychophysiol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100945","article-title":"A review of the effects of acute and chronic cannabinoid exposure on the stress response","volume":"63","author":"Glodosky","year":"2021","journal-title":"Front Neuroendocr."},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107477_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.2007.01001.x","article-title":"Higher cortisol awakening response in young adolescents with persistent anxiety problems","volume":"116","author":"Greaves-Lord","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107477_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psyneuen.2008.10.026","article-title":"Salivary cortisol as a biomarker in stress research","volume":"34","author":"Hellhammer","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13556210120056580","article-title":"Salivary cortisol measurements during a medically assisted alcohol withdrawal","volume":"6","author":"Keedwell","year":"2001","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/dar.12448","article-title":"A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia","volume":"36","author":"Kingston","year":"2017","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.psyneuen.2025.107477_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2025.107477_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psyneuen.2025.107477_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.psyneuen.2008.10.004","article-title":"Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge","volume":"34","author":"Kudielka","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108563","article-title":"Adverse childhood experiences (ACEs) and substance use disorder (SUD): A scoping review","volume":"221","author":"Leza","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psyneuen.2025.107477_bib28","doi-asserted-by":"crossref","first-page":"06260","DOI":"10.1016\/j.addbeh.2019.106260","article-title":"Increased cortisol levels are associated with low treatment retention in crack cocaine users","volume":"103","author":"Ligabue","year":"2020","journal-title":"Addict. Behav."},{"key":"10.1016\/j.psyneuen.2025.107477_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2017.02.014","article-title":"Searching objective criteria for patient assignment in addiction treatment","volume":"76","author":"L\u00f3pez-Go\u00f1i","year":"2017","journal-title":"J. Subst.Abuse Treat."},{"key":"10.1016\/j.psyneuen.2025.107477_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpsycho.2005.10.007","article-title":"Cortisol secretion patterns in addiction and addiction risk","volume":"59","author":"Lovallo","year":"2006","journal-title":"Int J. Psychophysiol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/acer.14913","article-title":"Intake assessments of salivary cortisol, survey responses, and adverse childhood experiences are associated with recovery success in an abstinence-based treatment program for substance use disorders","volume":"46","author":"Maddox-Rooper","year":"2022","journal-title":"Alcohol Clin. Exp. Res"},{"key":"10.1016\/j.psyneuen.2025.107477_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40618-014-0091-8","article-title":"Effects of cocaine on the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"37","author":"Manetti","year":"2014","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.psyneuen.2025.107477_bib33","first-page":"576","article-title":"A review of psychoendocrine research on the pituitary-adrenal cortical system","volume":"30","author":"Mason","year":"1968","journal-title":"Biopsy Sci. Med"},{"key":"10.1016\/j.psyneuen.2025.107477_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chc.2010.03.013","article-title":"Genetic and environmental risk factors for adolescent-onset substance use disorders","volume":"19","author":"Meyers","year":"2010","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.psyneuen.2025.107477_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108931","article-title":"Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatment","volume":"227","author":"Mukherjee","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psyneuen.2025.107477_bib36","unstructured":"Norwegian Directorate of Health., 2022. Nasjonal faglig retningslinje for legemiddelassistert rehabilitering (LAR) ved opioidavhengighet. [National guideline for medical-assisted rehabilitation for opioid dependence]. Oslo: Norwegian Directorate of Health."},{"key":"10.1016\/j.psyneuen.2025.107477_bib37","series-title":"Nasjonal faglig retningslinje for avrusing fra rusmidler og vanedannende legemidler. [National guideline for detoxification from drug and addictive medications IS-2211]","author":"Norwegian Directorate of Health","year":"2016"},{"key":"10.1016\/j.psyneuen.2025.107477_bib38","series-title":"Nasjonal faglig retningslinje for behandling og rehabilitering av rusmiddelproblem og avhengighet. [National guideline for treatment and rehabilitation of substance use problems and addiction]","author":"Norwegian Directorate of Health","year":"2017"},{"key":"10.1016\/j.psyneuen.2025.107477_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1280603","article-title":"Opioid-induced adrenal insufficiency: diagnostic and management considerations","volume":"14","author":"Patel","year":"2024","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0306-4530(02)00108-7","article-title":"Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change","volume":"28","author":"Pruessner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s42399-022-01164-7","article-title":"The Effect of 6 Months of Methadone Maintenance Therapy on Serum Levels of Cortisol, TSH, T4, and PTH Hormones","volume":"4","author":"Ravari","year":"2022","journal-title":"SN Compr. Clin. Med"},{"key":"10.1016\/j.psyneuen.2025.107477_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000054382","article-title":"Neuroendocrine-related effects of long-term, \u2018binge\u2019 cocaine administration: diminished individual differences in stress-induced corticosterone response","volume":"68","author":"Sarnyai","year":"1998","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2018.11.038","article-title":"Investigating associations between momentary stress and cortisol in daily life: What have we learned so far?","volume":"105","author":"Schlotz","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107477_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.35946\/arcr.v42.1.12","article-title":"Alcohol\u2019s negative emotional side: The role of stress neurobiology in alcohol use disorder","volume":"42","author":"Sinha","year":"2022","journal-title":"Alcohol Res"},{"issue":"16","key":"10.1016\/j.psyneuen.2025.107477_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172883","article-title":"Stress and substance use disorders: risk, relapse, and treatment outcomes","volume":"134","author":"Sinha","year":"2024","journal-title":"JCI"},{"issue":"4","key":"10.1016\/j.psyneuen.2025.107477_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0306-4530(98)00008-0","article-title":"Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion","volume":"23","author":"Smyth","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib47","author":"Snijders","year":"2011","journal-title":"multilevel Anal.: Introd. Basic Adv. multilevel Model."},{"key":"10.1016\/j.psyneuen.2025.107477_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psyneuen.2015.10.010","article-title":"Assessment of the cortisol awakening response: Expert consensus guidelines","volume":"63","author":"Stalder","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.psyneuen.2025.107477_bib49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.35946\/arcr.v34.4.11","article-title":"Stress and the HPA axis: role of glucocorticoids in alcohol dependence","volume":"34","author":"Stephens","year":"2012","journal-title":"Alcohol Res"},{"key":"10.1016\/j.psyneuen.2025.107477_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105391","article-title":"How to assess and interpret everyday life salivary cortisol measures: A tutorial on practical and statistical considerations","volume":"133","author":"Stoffel","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107477_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0376-8716(99)00017-4","article-title":"Individual risk factors for adolescent substance use","volume":"55","author":"Swadi","year":"1999","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107477_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00127-015-1104-4","article-title":"Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study","volume":"51","author":"Toftdahl","year":"2016","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107477_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.psyneuen.2025.107477_bib54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archgenpsychiatry.2009.50","article-title":"Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study","volume":"66","author":"Vreeburg","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2025.107477_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/PSY.0b013e3181d2f0c8","article-title":"Salivary cortisol levels in persons with and without different anxiety disorders","volume":"72","author":"Vreeburg","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2025.107477_bib56","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.psyneuen.2012.12.017","article-title":"Salivary cortisol levels and the 2-year course of depressive and anxiety disorders","volume":"38","author":"Vreeburg","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2025.107477_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems","volume":"31","author":"Vuong","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psyneuen.2025.107477_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1369-1600.2006.00018.x","article-title":"Clinical Study: Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence","volume":"11","author":"Walter","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psyneuen.2025.107477_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100148","article-title":"Drug-induced stress responses and addiction risk and relapse","volume":"10","author":"Wemm","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.psyneuen.2025.107477_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(02)03929-X","article-title":"Alterations in hypothalamic\u2013pituitary\u2013adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic \u2018binge\u2019 cocaine and withdrawal","volume":"964","author":"Zhou","year":"2003","journal-title":"Brain Res"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:43:26Z","timestamp":1762292606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453025002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S0306453025002008"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107477","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary cortisol trajectories among inpatients undergoing substance use disorder treatment: A prospective repeated-measures study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107477"}}